Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology

Table 10 Healthy Life Years (HLYs) potentially gained in 1 year by each element of the proposed intervention (TTH)

	Efficacy * uptake	Healthy Life Years per capita			Luxembourg N = 124,713		Russia N = 18,122,512	Spain N = 10,772,263
		Not treated	Treated	Gained	Affected individuals under treatment (n)	HLYs gained across population	Affected individuals under treatment (n)	HLYs gained across population	Affected individuals under treatment (n)	HLYs gained across population
CURRENT CARE: NO CONSUMER EDUCATION OR HEALTH-CARE PROFESSIONAL TRAINING
Acute management ASA 1 g or paracetamol 1 g	0.3340	0.0013	0.0009	0.0004	70,890	0.0001	14,833,657	0.00012	4,364,748	0.00011
Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g	0.3340	0.0013	0.0009	0.0004	0	0.0001	0	0.00012	0	0.00011
Total					70,890	0.0002	14,833,657	0.0026	4,364,748	0.00022
HLYs FOR OVERALL POPULATION					112		23,398		6885
TARGET CARE: WITH CONSUMER EDUCATION AND HEALTH-CARE PROFESSIONAL TRAINING
Acute management ASA 1 g or paracetamol 1 g	0.4847	0.0013	0.0007	0.0006	96,263	0.0002	20,142,825	0.00017	5,926,950	0.00016
Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g	0.4886	0.0013	0.0007	0.0006	3188	0.0002	666,981	0.00017	196,257	0.00017
Total					99,451	0.0004	20,809,806	0.0026	6,123,207	0.00033
HLYs FOR OVERALL POPULATION					163		34,090		10,031

ISSN: 1129-2377